GLP1R and type 2 diabetes mellitus: While the biological relevance and pathological impact is yet to be fully clarified, clinical studies have demonstrated that GLP-1 secretion is decreased in human subjects with diabetes, which highlights the potential use of GLP-1 as a therapeutic approach for type 2 diabetes.